Register Now

Vision

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque rutrum velit id ipsum consectetur, ut consectetur augue ullamcorper. Duis aliquam semper quam, quis porttitor lectus laoreet quis. Sed mollis sagittis convallis. Sed ultrices purus sed turpis accumsan, id euismod felis egestas. Cras ultrices velit id dolor tincidunt auctor. Morbi et elementum sapien, condimentum accumsan odio. Vivamus at interdum odio. Donec vel consequat elit, id vulputate dolor. Integer in mi vel nibh suscipit tristique vitae ac nunc. Sed ac magna id lorem aliquet ornare in sed nulla. Aliquam eget erat nisl.

Dr. Rob Tanguay (CO-CHAIR)

BSc (Hons), MD, FRCPC, CISAM, CCSAM

Dr. Tanguay is a psychiatrist who completed two fellowships, one in Addiction Medicine and Pain Medicine. He is a clinical assistant professor with the departments of Psychiatry and Surgery at the Cumming School of Medicine, University of Calgary.

He is the co-chair of the internationally recognized Alberta Pain Strategy and helps lead the Alberta Virtual Pain Program implementation. He is the co-founder and co-developer of the Community Rapid Access Addiction Medicine (RAAM) clinic for AHS where he works clinically.

Dr. Tanguay is member of the Calgary Police Commission, legislated to manage the annual budget ($568 million) as well as to establish policies providing for efficient and effective policing. He is a director for the Alberta Association of Police Governance and the Criminal Code Review Board. He is the Co-Chair of the Western Canadian Addiction Forum and Chair of the Canadian Addiction Counsel. Dr. Tanguay has been heavily involved in health policy including helping to lead the Alberta Psychedelic Legislative Committee and the Alberta Safe Supply Legislative Committee. He was a member of the Alberta Recovery Expert Advisory Panel directly advising the Alberta Minister of Addiction and Mental Health. He was a member of the Public Health Emergencies Governance Review Panel for the Government of Alberta and was a member of the Supervised Consumption Review Committee. He also sits on the Policy Committee for the Canadian Society of Addiction medicine (CSAM) where he was a former director.

Dr. Tanguay has been recognized for his work and is the 2021 Royal College of Physicians and Surgeons of Canada recipient of the Early Career Leadership Award, was inducted into the University of Lethbridge Alumni Honour Society, and is a recipient of the Queen Elizabeth II Platinum Jubilee Medal.

Dr. Tanguay has presented 114 invited, plenary, and keynote lectures on three continents speaking on policy, addiction, pain, and mental health. He has received $9,327,494 in operational and research grants. Academically, he is involved in research in trauma, addiction, chronic pain, opioids, cannabis, and psychedelics and is a member of the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research & Education at the University of Calgary.

Dr. Michael Krausz (co-chair)

MD, PhD, FRCPC

Dr. Michael Krausz is originally from Hamburg, Germany, where he was trained at the University Medical Center Hamburg-Eppendorf as a registered nurse. Following this he completed a residency in Adult Psychiatry and his Doctor of Philosophy, where he examined the associations between psychosis and addictions. In the mid 1990s, he became a founding director of the Centre of Interdisciplinary Addiction Research at the University of Hamburg and retained directorship at the centre until 2004. As a founding director, he was responsible for the German Heroin Trial, the European Cocaine Project, and several other notable addiction-related trials. He also served as Editor-In-Chief of two well-established European scientific journals; Suchttherapie and European Addiction Research.

Dr. Krausz is a founding member of the International Society of Addiction Medicine (ISAM), a Member of the Scientific Advisory Board of the Canadian Centre for Substance Abuse (CCSA) and the e-Mental Health Steering Committee for the Mental Health Commission of Canada (MHCC), and is Section Chair of the Informatics and Telecommunications in Psychiatry and Addiction Psychiatry Sections of the World Psychiatric Association (WPA) and Co-Chiar of the Public Policy and Psychiatry Section, WPA.

Dr. Krausz relocated permanently to Vancouver, Canada in 2007, and from 2009-2012 he was the Medical Director of the Burnaby Centre for Mental Health and Addiction with Vancouver Coastal Health. Currently, he is a Professor of Psychiatry at the University of British Columbia (UBC), the Providence Health Care/UBC Leading Edge Endowment Fund (LEEF) B.C. Leadership Chair in Addiction Research, and a Founding Fellow of the UBC Institute of Mental Health.

As a Senior Scientist at the Centre for Health Evaluation & Outcome Sciences (CHÉOS) and head of the Addictions and Concurrent Disorders Group at CHÉOS, Dr. Krausz’s research explores the relationship between early life trauma, substance use disorders, and other mental illnesses. His research includes the At Home/Chez Soi Study, the B.C. Health of the Homeless Survey, and the Study to Assess Long-Term Opioid Maintenance Effectiveness (SALOME).

More recently, Dr. Krausz has extended his expertise to include e-mental health. The Bell Youth Mental Health IMPACT Project (2012) was Dr. Krausz’s first endeavour in this area. Bell Canada’s philanthropic support in the amount of $1 million as part of their Let’s Talk Initiative was critical seed funding in the development of a new mental health platform, WalkAlong.ca, designed to provide youth who are experiencing depression and anxiety with resources to help foster mental wellness. In 2014, he was recognized for his tireless research and advocacy related to substance use, mental health, and housing security with the City of Vancouver’s Healthy City for All Award of Excellence.

The current public health emergency based on the opioid overdose crisis and a historic mortality due to a mental illness is a critical challenge. We all need to step up our response through:

  • Research on the root causes, risks and effective interventions, strengthening infrastructure and funding. The existing patterns of use and disastrous consequences require and adaptation to the situation, like in a pandemic.
  • Engagement with high – risk patients to building on their needs early. Following positive experiences in other parts of care, we need early intervention structures and interventions.
  • A clinical trajectory providing the framework from prevention, lifestyle mentoring to counselling and early intervention to an intense crisis management with easy access, virtual care and patient empowerment.
  • Specialty interventions for the most vulnerable informed by scientific evidence.

The Canadian Academy for Addiction Psychiatry (CAAP) wants to attract every engaged professional in the field to strive towards outcome oriented collaboration to achieve high quality care and synergy caring for the most vulnerable.